Health
Roche gantenerumab improves biomarkers in inherited form of Alzheimer’s disease – PMLiVE
However, anti-amyloid antibody did not show evidence of cognitive benefit for patients
A new study, published in Nature Medicine, has showed that Roche’s investigational candidate gantenerumab led to improvements in a number of biomarkers in patients with an inherited form of Alzheimer’s disease.
In the DIAN-TU-001 trial, researchers from…
Continue Reading
-
Noosa News19 hours agoPolice officer who tracked Toyah Cordingley’s phone gives evidence at Rajwinder Singh’s murder trial
-
General18 hours agoARIA Awards 2025 winners: Amyl & The Sniffers and Ninajirachi dominate
-
General20 hours agoPerth man charged after investigation into organised crime and tobacco store attacks
-
General10 hours agoSmall-town cleaner finds himself in legal battle with EnduroShield over product packaging